(“the Company”) and its Subsidiary (“the Group”) would like to clarify the change in operating result for the first quarter ended 31 March 2019, which changed in revenue and net profit compared with the

. “underlying share” means a newly issued share provided for the exercising of rights under a convertible bond. “exercising of conversion right” means the conversion of convertible bond into shares, whether by

million or 10.3%(y-o-y) , representing Net profit margin of 26.9% and 27.5% respectively. Thus have earnings per share of Bt0.40 and Bt1.22. In Q3/2019 and the nine months of 2019, the Group has been

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

which decreasing by Bt66.2 million or -27.3%(y-o-y) and of Bt40.9 million or -7.2%(y-o-y), representing Net profit margin of 19.2% and 27.8% respectively. Thus have earnings per share of Bt0.28 and Bt0.82

approve the change of signing authority as follows Original Directors with signing authority include Mr. Paisarn Taecharatanachai or Mrs. Suneat Kewkacha or Ms. Amponsri Kewkacha or Mr. Pin Kewkacha or Mrs

the Annual General Meeting of Shareholders to approve the change of signing authority as follows Original Directors with signing authority include Mr. Paisarn Taecharatanachai or Mrs. Suneat Kewkacha or

reported is d ifferent from that reported in the previous period. Operating Highlights in Q1/2020 Q1/19 Q4/19 Q1/20 Change +/(-) (Unit: Million Baht) QoQ YoY Operating revenue 9,067 18,279 18,308 0% 102

, please provide the information on the change of securities holding as a result of the commencement or termination of status of a concert party or the acquisition or termination of status of a juristic

party or the acquisition or termination of status of a juristic person under Section 258, please provide the information on the change of securities holding as a result of the commencement or termination